Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy

• Published in: Scientific reports Vol. 6; no. 1; p. 26684
• Main Authors: Cao, Jinlin, Yuan, Ping, Wang, Luming, Wang, Yiqing, Ma, Honghai, Yuan, Xiaoshuai, Lv, Wang, Hu, Jian
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 24.05.2016; Nature Publishing Group
• Subjects: 136919; 365441; 692/308/409; 692/4028/546; 692/700/1750/2094; Cancer; Classification; Esophageal cancer; Esophagus; Gastrointestinal surgery; Humanities and Social Sciences; Medical prognosis; Metastases; multidisciplinary; Nodes; Nomograms; Science; Survival
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep26684

The aim of this study was to construct an effective clinical nomogram for predicting the survival of esophageal cancer patients after esophagectomy. We identified esophageal cancer patients ( n  = 4,281) who underwent esophagectomy between 1988 and 2007 from the Surveillance, Epidemiology and End Results (SEER) 18 registries database. Clinically significant parameters for survival were used to construct a nomogram based on Cox regression analyses. The model was validated using bootstrap resampling and a Chinese cohort ( n  = 145). A total of 4,109 patients from the SEER database were included for analysis. The multivariate analyses showed that the factors of age, race, histology, tumor site, tumor size, grade and depth of invasion and the numbers of metastases and retrieved nodes were independent prognostic factors. All of these factors were selected into the nomogram. The nomogram showed a clear prognostic superiority over the seventh AJCC-TNM classification (C-index: SEER cohort, 0.716 vs 0.693, respectively; P  < 0.01; Chinese cohort, 0.699 vs 0.680, respectively; P  < 0.01). Calibration of the nomogram predicted the probabilities of 3- and 5-year survival, which corresponded closely with the actual survival rates. This novel prognostic model may improve clinicians’ abilities to predict individualized survival and to make treatment recommendations.